Provided by Tiger Trade Technology Pte. Ltd.

Acumen Pharmaceuticals, Inc.

2.92
+0.06002.10%
Post-market: 2.930.0100+0.34%19:30 EDT
Volume:318.28K
Turnover:924.75K
Market Cap:210.86M
PE:-1.78
High:2.99
Open:2.93
Low:2.84
Close:2.86
52wk High:3.60
52wk Low:1.21
Shares:72.21M
Float Shares:37.05M
Volume Ratio:0.81
T/O Rate:0.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6370
EPS(LYR):-2.0035
ROE:-120.50%
ROA:-45.77%
PB:3.68
PE(LYR):-1.46

Loading ...

Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2025

Major Issues Report

Form 8-K - Current report